-
Mapping the Landscape of Digital Healthcare Services Delivered by Specialized Oncology Hospitals in China: Qualitative Analytical Study
Sep 9, 2025, 16:22 PM -
Can Generative Artificial Intelligence (GenAI) Be Leveraged to Automate Scoping Searches of Systematic Literature Reviews (SLRs)?
Sep 9, 2025, 16:22 PM -
Garbage In, Garbage Out: Can AI Reduce the Impact of Human Error in eCOA Localized Text Migration?
Sep 9, 2025, 16:22 PM -
Clinical Benefit vs. Reimbursement Decisions: Examining Misalignments Between ESMO-MCBS and HTA Outcomes in Oncology
Sep 9, 2025, 16:22 PM -
The AI-in-RWE Transparency (AIRT) Checklist: Essential and Desirable Standards for AI-Enhanced Real-World Evidence
Sep 9, 2025, 16:22 PM -
Human Metapneumovirus (hMPV): Systematic Literature Review of Economic and Humanistic Disease Burden in Adults
Sep 9, 2025, 16:22 PM -
A Real-World Study on Italian Administrative Healthcare Data to Describe Patients With Chronic Obstructive Pulmonary Disease by Therapeutic Pattern and Exacerbation Rate
Sep 9, 2025, 16:22 PM -
The Economic Case for Gender Equity: How Closing the Women’s Health Gap Benefits Healthcare Systems and Economies
Sep 9, 2025, 16:22 PM -
Ensuring Greater Acceptance of Minimal Residual Disease Negativity in Health Technology Assessments in Multiple Myeloma: Key Barriers and Opportunities
Sep 9, 2025, 16:22 PM -
Surviving but Not Earning? Long-term Income Trajectories in Working-Age mIDH Glioma Patients: Stratification by Radiotherapy/Chemotherapy Exposure
Sep 9, 2025, 16:22 PM -
The Health Impact of Pembrolizumab Plus Chemotherapy in the First-Line Treatment for Metastatic Triple-Negative Breast Cancer (TNBC) in Türkiye
Sep 9, 2025, 16:22 PM -
From Evidence to Enforcement? Implications of the 2025 SVR Report for Pharmaceutical Pricing and Orphan Drug Policy in Germany
Sep 9, 2025, 16:22 PM -
Navigating Joint Clinical Assessment in Europe: Strategic Roadmap and Recommendations for Health Technology Developers
Sep 9, 2025, 16:22 PM -
COVID-19 mRNA-1273 Vaccination in the UK: A Comparative Modeling Study of Alternative Eligibility Criteria
Sep 9, 2025, 16:22 PM -
Evaluating the Economic Impact of Worksite Physical Activity Interventions in Denmark: An Employer’s Perspective
Sep 9, 2025, 16:22 PM -
Assessment of Health State Utilities Associated With Treatment for Chronic Hepatitis B Virus (HBV) Infection
Sep 9, 2025, 16:22 PM -
Development of a Multidimensional HTA Evaluation for the Introduction of Clesrovimab in Pediatric RSV Prevention: An Integrated Methodological Approach
Sep 9, 2025, 16:22 PM -
Cross-Sectional Cohort Design Offers an Efficient Alternative to Prospective Cohort Design in Real-World Studies (RWS)
Sep 9, 2025, 16:22 PM -
Impact of the COVID-19 Pandemic on Healthcare Expenditure
Sep 9, 2025, 16:22 PM -
Comprehensive Uncertainty Assessment in Economic Evaluations of AI-Based Health Technologies: Pitfalls and Recommendations
Sep 9, 2025, 16:22 PM
